MRI-guided Radiation Therapy for Cancer

This trial explores a new method of using radiation therapy to treat individuals with solid tumors that have metastasized. The treatment, MRI-guided Stereotactic Body Radiation Therapy, uses MRI (a detailed scan) to guide radiation precisely, potentially protecting healthy tissue and delivering treatment in just one day. Individuals with one to three tumors outside the brain and spine, who have not previously received overlapping radiation, may qualify for this trial.

As an unphased trial, this study provides patients with access to innovative treatment approaches that could potentially improve outcomes.

Research has shown that MRI-guided SBRT, a type of precise radiation therapy, is safe and easy for patients to handle. Studies have found that this treatment greatly reduces side effects. For example, patients experienced fewer urinary and bowel problems compared to other radiation therapies. In one study, only 27% of patients experienced these side effects, which is quite low.

Additionally, MRI-guided SBRT is well-tolerated for treating cancer that has spread to the liver. It also lowers the risk of urinary system issues, with only a 16% chance of moderate side effects.

MRI-guided Stereotactic Body Radiation Therapy (SBRT) is unique because it combines precise imaging with targeted radiation delivery, allowing doctors to focus on cancer cells while minimizing damage to healthy tissues. Unlike traditional radiation therapy, which often uses CT scans for guidance, this method uses real-time MRI, providing clearer images and more accurate targeting. Researchers are excited because this approach could lead to fewer side effects and potentially better outcomes, offering a significant advancement over standard treatments like conventional radiation therapy.

Research has shown that MRI-guided stereotactic body radiation therapy (SBRT), which participants in this trial will receive, offers a promising treatment for patients with metastatic cancer. Studies have found that MRI-guided SBRT provides high accuracy, protecting healthy tissue while effectively targeting tumors. Specifically, one study found that this method controlled tumors in the abdomen and pelvis in over 85% of patients after two years. MRI-guided SBRT also causes fewer side effects compared to traditional methods using CT scans. Overall, this treatment is safe, well-tolerated, and has the potential to effectively control tumors.¹²⁶⁷⁸